Trinity Biotech plc
Price Action
Technical Summary
DOWNTRENDTrinity Biotech plc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 5), showing significant lag compared to the market leaders. Earnings growth of 22% provides fundamental context to the price action. However, RSI is deeply oversold at 24, suggesting potential for a mean-reversion bounce.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.58 | -26.63% | BELOW |
| 50 SMA | $0.61 | -29.91% | BELOW |
| 100 SMA | $0.66 | -34.58% | BELOW |
| 150 SMA | $0.73 | -41.54% | BELOW |
| 200 SMA | $0.81 | -46.97% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TRIB in an uptrend right now?
TRIB has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is TRIB overbought or oversold?
TRIB's RSI (14) is 24. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is TRIB outperforming the market?
TRIB has a Relative Strength (RS) Rating of 5 out of 99. TRIB is currently lagging the broader market.
Where is TRIB in its 52-week range?
TRIB is trading at $0.43, which is 2% of its 52-week high ($17.20) and 1% above its 52-week low ($0.31).
How volatile is TRIB?
TRIB has a Beta of 1.89 and 52-week volatility of 163%. It's more volatile than the S&P 500 - expect bigger swings.